US Patent Issued to Liverpool School of Tropical Medicine, The University of Liverpool, Eisai R&D Management on Feb. 10 for "Anti-wolbachia pyrido[2,3-dpyrimidine compounds" (British, American Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,675, issued on Feb. 10, was assigned to Liverpool School of Tropical Medicine (Liverpool, Great Britain), The University of Liverpool (Liverpool, Great Britain) and Eisai R&D Management Co. Ltd. (Bunkyo-Ku, Japan).

"Anti-wolbachia pyrido[2,3-dpyrimidine compounds" was invented by Stephen A. Ward (Liverpool, Great Britain), Mark J. Taylor (Liverpool, Great Britain), Paul M. O'Neill (Liverpool, Great Britain), Weiqian David Hong (Liverpool, Great Britain) and Farid Benayoud (North Andover, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of Formulae I and II as defined herein, and salts and solvates there...